Study of Stellate Ganglion Block and Prolonged Exposure Therapy for PTSD in Military Members
Comparing Real and Sham Injections to Improve PTSD Treatment Outcomes
Led by The University of Texas Health Science Center at San Antonio · Updated on 2025-09-04
140
Participants Needed
2
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
This clinical trial focuses on military service members or retirees aged 18 to 65 with post-traumatic stress disorder PTSD. It aims to compare the effects of combining Massed Prolonged Exposure PE, a type of behavioral therapy for PTSD, with a stellate ganglion block SGB, which is an injection of a local anesthetic in the neck, against Massed PE combined with a sham injection. The study also seeks to understand how differences in psychophysiological responses during the exposure therapy relate to treatment outcomes.
Participants will receive ten 90-minute Massed PE sessions conducted by qualified therapists over two weeks, Monday through Friday, involving about four to six hours of treatment daily including therapy and out-of-session assignments. Between the first and second PE sessions, participants will be randomly assigned to receive either a one-time SGB injection using 6.5cc of Ropivacaine or a sham injection of normal saline. After the initial treatment, participants may have three booster sessions offered at 1, 3, and 7 weeks post-treatment. Qualified medical personnel will administer the injections under standard procedures with monitoring during and after the procedure.
Throughout the study, participants will undergo assessments before, during, and after treatment, including follow-ups at 1, 3, and 6 months after completing PE. The main outcomes measured include changes in PTSD symptoms using the Clinician-Administered PTSD Scale and the PTSD Checklist. Additional evaluations include questionnaires on depression, anxiety, and trauma-related thoughts, as well as psychophysiological measures such as skin response, heart rate, and movement during the two-week treatment period. Participants in the sham injection group will be offered the active SGB after the one-month assessment. The total study duration includes treatment and follow-up assessments lasting several months.
CONDITIONS
Brief Title
Combining Stellate Ganglion Block With Prolonged Exposure for PTSD
Research Team
A
Amanda Flores
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
The University of Texas Health Science Center at San Antonio
Lead Sponsor
United States Department of Defense
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
A single injection of ropivacaine into the stellate ganglion designed to modulate sympathetic nervous system activity as an adjunct to psychotherapeutic care.
A single injection of normal saline into the stellate ganglion, used as placebo control for procedural and psychological effects.
A structured, guideline-endorsed psychotherapeutic program involving repeated and systematic sessions of trauma-related exposures, usually delivered weekly or intensively over several weeks.
Role in trial
Investigational intervention arm; participants randomized to receive active SGB with ropivacaine.
Placebo control; participants randomized to receive sham SGB with saline injection.
External first-line guideline comparator; not part of randomization but established as standard treatment for PTSD.
Primary use
Adjunctive intervention to rapid or intensive Prolonged Exposure, aiming to accelerate or enhance PTSD symptom reduction.
Control to evaluate the effect of SGB versus placebo on PTSD symptoms during PE therapy.
Psychotherapeutic approach to reduce PTSD symptoms by systematic exposure to trauma cues, recommended as first-line treatment.
How it is given or performed
One-time injection of ropivacaine into the stellate ganglion, performed under medical guidance at a military treatment facility.
One-time injection of normal saline into the same anatomical site, mimicking the procedural experience without active drug.
Delivered in multiple outpatient sessions by a trained therapist; weekly or intensive daily schedules supported by evidence.
Evidence status
Evidence from small randomized trials and case series suggests SGB may reduce PTSD symptoms, but large-scale and long-term efficacy remains to be established.
Used as placebo; evidence shows no direct clinical benefit for PTSD beyond expectancy or procedural effects.
Multiple large randomized trials confirm PE’s effectiveness in reducing PTSD symptoms in military and civilian populations; considered gold standard therapy.
Important limitations
Limited data on long-term outcomes, safety concerns related to invasive nerve block procedures, and unclear durability of effect. Efficacy may vary based on trauma subtype and individual response.
Placebo, does not address underlying PTSD symptoms. May still induce procedural discomfort or side effects.
Requires sustained commitment to therapy, can be emotionally challenging, not all patients achieve full remission, and some may discontinue due to distress. Accessibility may vary depending on therapist availability.
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years - 65Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Active duty or retired military service members aged 18 to 65 years
Diagnosed with PTSD using the Clinician-Administered Posttraumatic Stress Scale
Able to speak and read English
Eligible for care at a military treatment facility where the stellate ganglion block will be administered
You will not qualify if you...
Current severe suicidal thoughts requiring immediate attention
Current manic episode or psychotic symptoms needing urgent care
Moderate to severe substance use requiring intervention
Other severe psychiatric disorders as primary diagnosis
Pregnancy or breastfeeding
Current use of anticoagulants
History of bleeding disorders
Infection or mass at the injection site
Recent myocardial infarction within 6 months
Abnormal heart rate or rhythm issues
Symptomatic low blood pressure
Phrenic or laryngeal nerve palsy
History of glaucoma
Uncontrolled seizure disorder
Allergy to local anesthetics
Current use of Class III antiarrhythmic medications
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
screening and enrollment visit
Treatment
Duration - 2 weeks
Participants receive individual 90-minute therapy sessions combined with out-of-session assignments, totaling approximately four to six hours of treatment per day, Monday through Friday, for two weeks. The stellate ganglion block injection or sham injection is administered between the first and second therapy sessions with medical supervision and a one-hour recovery period.
Daily visits Monday through Friday for 2 weeks, including injection and therapy sessions
Follow-up
Duration - Up to 6 months
Participants are offered three booster therapy sessions at 1, 3, and 7 weeks after treatment completion. Assessments are conducted at 1, 3, and 6 months following treatment to monitor progress.
1 visit at 1 week, 1 visit at 3 weeks, 1 visit at 7 weeks, and follow-up visits at 1, 3, and 6 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Study of EEG Neurofeedback Using Prism System to Reduce PTSD Symptoms in Adults Aged 18 to 65
Evaluating New PTSD Tests CAPS-5 and PSSI-5 in Adults Who Are Active Duty Military or Veterans
Evaluating How Course Delivery and Social Learning Affect Internet Therapy for Canadian Public Safety Workers
Study of Stellate Ganglion Block and Prolonged Exposure Therapy for PTSD in Military Members
Comparing Real and Sham Injections to Improve PTSD Treatment Outcomes
Personalized Study of Lorazepams Effects on GABA Brain Activity in Veterans with PTSD
Comparing Computer Monitor and Augmented Reality for 3MDR Therapy in Treating PTSD
Memory-Boosted Cognitive Processing Therapy for Older Veterans with PTSD
Improving PTSD Treatment by Adding a Writing Intervention to Cognitive Processing Therapy and Prolonged Exposure
Study of Cognitive Processing Therapy and Self-Compassion Therapy for PTSD and Trauma-Related Mental Contamination After Sexual Trauma
Effect of Energy Resonance by Skin Stimulation on Stress in Adults Recovering in Post-ICU Rehabilitation
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel: A Randomized Clinical Trial.
The Efficacy of the Stellate Ganglion Block as a Treatment Modality for Posttraumatic Stress Disorder Among Active Duty Combat Veterans: A Pilot Program Evaluation.